Kaplan B S, Mills M
Renal Service-Renal Laboratory, Montreal Children's Hospital, Quebec, Canada.
Clin Nephrol. 1988 Oct;30(4):193-6.
Clinical observations and experimental studies have pointed to a role for leukocytes in the pathogenesis of the typical or epidemic form of the hemolytic uremic syndrome. As a result of these observations we measured serum elastase levels and the levels of two protease inhibitors, alpha-1-antitrypsin and alpha-2-macroglobulin in 12 patients with this syndrome. The serum elastase levels were significantly elevated in patients compared with normal individuals (421 +/- 278 vs 91 +/- 27 mg/dl, p less than 0.005) and patients with renal diseases not caused by hemolytic uremic syndrome (191 +/- 254 mg/dl, p less than 0.025). The serum alpha-1-antitrypsin levels were also significantly elevated: hemolytic uremic syndrome vs normals (774 +/- 260 vs 285 +/- 98 ng/ml, p less than 0.0001); and in hemolytic syndrome compared with patients with renal diseases not caused by hemolytic uremic syndrome (774 +/- 260 vs 335 +/- 131 ng/ml, p less than 0.0001). There were no significant differences in the alpha-2-macroglobulin levels among the three groups. There was a significant correlation between the serum elastase levels and the total white cell counts as well as between the elastase and the polymorphonuclear cell counts but not among any of these values and the serum creatinine concentrations. These results provide additional evidence favoring the possibility that leukocytes are activated in patients with hemolytic uremic syndrome.
临床观察和实验研究表明,白细胞在典型或流行性溶血尿毒综合征的发病机制中起一定作用。基于这些观察结果,我们检测了12例该综合征患者的血清弹性蛋白酶水平以及两种蛋白酶抑制剂——α-1抗胰蛋白酶和α-2巨球蛋白的水平。与正常个体相比,患者的血清弹性蛋白酶水平显著升高(421±278 vs 91±27mg/dl,p<0.005),与非溶血尿毒综合征所致肾病患者相比也显著升高(191±254mg/dl,p<0.025)。血清α-1抗胰蛋白酶水平同样显著升高:溶血尿毒综合征患者与正常个体相比(774±260 vs 285±98ng/ml,p<0.0001);溶血尿毒综合征患者与非溶血尿毒综合征所致肾病患者相比(774±260 vs 335±131ng/ml,p<0.0001)。三组间α-2巨球蛋白水平无显著差异。血清弹性蛋白酶水平与白细胞总数之间以及弹性蛋白酶与多形核细胞计数之间存在显著相关性,但这些值与血清肌酐浓度之间均无相关性。这些结果提供了更多证据,支持溶血尿毒综合征患者白细胞被激活的可能性。